MB-CART19.1 in Refractory SLE
NCT06189157
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
SLE - Systemic Lupus Erythematosus
Interventions
BIOLOGICAL:
MB-CART19.1
Sponsor
Miltenyi Biomedicine GmbH